Recent publications on Cancer

Kshitiz, Afzal J, Suhail Y, Ahn EH, Goyal R, Hubbi ME, Hussaini Q, Ellison DD, Goyal J, Nacev B, Kim DH, Lee JH, Frankel S, Gary K, Chien AJ, Levchenko A. Control of the interface between heterotypic cell populations reveals the mechanism of intercellular transfer of signaling proteins. Integr Biol (Camb). 2015, Feb 26. [Epub ahead of print]. PubMed

Kramer BS, Elmore JG. Projecting the benefits and harms of mammography using statistical models: proof or proofiness? J Natl Cancer Inst. 2015 Apr 29;107(7). pii: djv145. doi: 10.1093/jnci/djv145. Print 2015 Jul. PubMed

Buist DM, Ichikawa L, Wernli KJ, Lee CI, Henderson LM, Kerlikowske K, Bowles EJ, Miglioretti DL, Specht J, Rauscher G, Sprague B, Onega T, Lee JM. Facility variability in examination indication among women with prior breast cancer: implications and the need for standardization. J Am Coll Radiol. 2020 Jan 28. pii: S1546-1440(19)31483-8. doi: 10.1016/j.jacr.2019.12.020. [Epub ahead of print]. PubMed

Coury J, Miech EJ, Styer P, Petrik AF, Coates KE, Green BB, Baldwin LM, Shapiro JA, Coronado GD. What's the "secret sauce"? how implementation variation affects the success of colorectal cancer screening outreach. Implement Sci Commun. 2021 Jan 11;2(1):5. doi: 10.1186/s43058-020-00104-7. PubMed

Winer RL, Lin J, Anderson ML, Tiro JA, Meenan RT, Hansen K, Gao H, Sparks A, Greene DN, Kilgore-Martin S, Green BB, Buist DSM. Design of a pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake in a U.S. healthcare system: the STEP trial. Contemp Clin Trials. 2022 Oct 11:106960. doi: 10.1016/j.cct.2022.106960. PubMed

Burnside ES, Lasarev MR, Sprague BL, Miglioretti DL, Alexandridis RA, Lee JM, Pisano ED, Smith RA. The importance of outcomes ascertainment to accurately assess mammography screening cancer detection rate: a simulation study. J Am Coll Radiol. 2023 Nov 1:S1546-1440(23)00845-1. doi: 10.1016/j.jacr.2023.09.014. PubMed